Radiation Oncology

Roger W. Byhardt, MD, FACR Professor of Radiation Oncology Department of Radiation Oncology 8701 Watertown Plank Road Milwaukee, WI 53226 (414) 805-4498

Curriculum Vitae

Patient Care Emphases

• Head and Neck Cancer
• Lung Cancer
• General Radiation Oncology

Clinical Practice Locations

• Senator Joseph Andrea Cancer Center, Kenosha, at St. Catherine's Campus of United Healthcare Systems: (262) 577-8206
• The Alyce and Elmer Kraemer Cancer Care Center: (262) 306-7735

Education

• Doctor of Medicine, Medical College of Wisconsin, Milwaukee, WI (1968).

Training

• Residency Radiation Oncology, St. Joseph Hospital, Denver, CO (1969-1972).
• Internship Radiation Oncology, St. Joseph Hospital, Denver, CO (1968-1969).

Certifications

• Radiation Oncology, American Board of Radiology (1973).

Representative Publications (last 5 years)

• Werner-Wasik M, Paulus R, Curran WJ, Byhardt R. Acute esophagitis and late lung toxicity in concurrent radiotherapy trial in patients with locally advanced non-small cell lung cancer: Analysis of the Radiation Therapy Oncology Group (RTOG) database. Clin Lung Cancer 12(4):245-51, 2011.
• Watkins Bruner D, James JL, Bryan CJ, Pisansky TM, Rotman M, Corbett T, Speight J, Byhardt R, Sandler H, Bentzen S, Kachnic L, Berk L. Randomized, double-blinded, placebo-controlled crossover trial of treatin erectile dysfunction with sildenafil after radiotherapy and short-term androgen deprivation therapy: Results of RTOG 0215. J Sex Med 8(4):1228-38, 2011.
• Firat S, Byhardt RW, Gore E. The effects of comorbidity and age on RTOG study enrollment in stage III non-small cell lung cancer patients who are eligible for RTOG studies. Int J Radiat Oncol Biol Phys, 78(5): 1394-9, 2010.
• Bradley JD, Moughan J, Graham MV, Byhardt R, Govindan R, Fowler J, Purdy JA, Michalski JM, Gore E, Choy H. A phase I/II radiation dose escalation study with concurrent chemotherapy for patients with inoperable stage I to III non-small cell lung cancer: Phase I results of RTOG 0117. Int J Radiat Oncol Biol Phys 77(2):367-72, 2010.
• Bradley JD, Bae K, Graham MV, Byhardt R, Govindan R, Fowler J, Purdy JA, Michalski JM, Gore E, Choy H. Primary analysis of the phase II component of a phase I/II dose intensification study using three-dimensional conformal radiation therapy and concurrent chemotherapy for patients with inoperable non-small cell lung cancer: RTOG 0117. J Clin Oncol 28(14):2475-80, 2010.
• Pollack A, Bae K, Khor LY, Al-Saleem T, Hammond ME, Ventkatesan V, Byhardt RW, Asbell SO, Shipley WU, Sandler HM. Clin Cancer Res 15(17):5478-84, 2009.
• McAleer M, Moughan J, Byhardt R, Cox J, Sause W, Komaki R. Does response to induction chemotherapy predict survival for locally advanced non-small cell lung cancer?  Secondary analysis of RTOG 8804/8808. Int J Radiat Oncol Biol Phys, 76(3):802-8, 2009.   
• Khor LY, Bae K, Paulus R, Al-Saleem T, Hammond ME, Grignon DJ, Che M, Venkatesan V, Byhardt RW, Rotman M, Hanks GE, Sandler HM, Pollack A. MDM2 and Ki-67 predict for distant metastasis and mortality in men treated with radiotherapy and androgen deprivation for prostate cancer: RTOG 92-02. J Clin Oncol 27(19):3177-84, 2009. 
• Sarna L, Swan S, Langer C, Werner-Wasik M, Nicolaou N, Komaki R, Machtay M, Byhardt R, Wasserman T. Clinically Meaningful Differences in Patient Reported Outcomes (PROs) with Amifostine in Combination with Chemoradiation for Locally Advanced Non-small Cell Lung Cancer. An Analysis of RTOG 9801. Int J Radiat Oncol Biol Phys 72(5):1378-1384, 2008.
• Calvin D,  Hammond E., Pajak T, Trotti A, Meredith R, Rotman M, Jones C, Byhardt R, Demas W, Ang,K, Fu, K.  Microvessel Density >= 60 Does Not Predict for Outcome After Radiation Treatment for Locally Advanced Head and Neck Squamous Cell Carcinoma (HNSCC): Results of a Prospective, Translational Study from the Radiation Therapy Oncology Group (RTOG) 90-03 Trial. Am J Clin Oncol 30(4):406-419, 2007.